Aim: The translocation (6; 9)(p23; q34) is a rare cytogenetic aberration found in patients with
acute myeloid leukemia (AML)(about 1% of all AML), and correlates with poor clinical …

The t (4; 12)(q12; p13) in acute myeloid leukemia (AML) is a rare finding with less than 30
cases described in the literature. The few cases reported show that this subtype of AML …

Acute myelogenous leukemia (AML) with the translocation t (6; 9)(p23; q34) is a rare
disease entity with a poor prognosis. We report three patients; two were diagnosed with AML …

The present study reviewed three patients with acute myeloid leukemia (AML) who had the
specific genetic abnormality t (16; 21)(p11; q22). To investigate the clinical and laboratory …

Objective To investigate the clinical and laboratory characteristics of acute myeloid leukemia
(AML) with t (16; 21)(p11; q22) translocation. Methods Two patients diagnosed by …

Abstract The translocation (6; 9)(p23; q34) is a rare cytogenetic aberration found in patients
with acute myeloid leukemia (AMD. The clinical, morphologic, and immunophenotypic …

Acute myeloid leukemia (AML) patients with t (8; 16)(p11. 2; p13) constitute a small
subgroup with a distinct genetic and clinical profile. We present a unique case of a female …

Cytogenetics has a pivotal role in risk stratification of acute myeloid leukemia (AML). We
report a case of AML with at (4; 12)(q12; p13). To the best of our knowledge, there are about …

Discussion Translocation (16; 21)(p11; q22) is a uncommon but recurrent cytogenetic
abnormality described in acute myeloid leukaemia (AML) and one case of chronic myeloid …

Objective To analyze the biological and clinical characteristics of acute myeloid leukemia
(AML) with t (16; 21)(p11; q22), and the curative effect and prognosis. Methods A …